Genpact Stock Plummets to New 52-Week Low at $33.67

Genpact has reached a new 52-week low, trading at USD 33.67 as of April 27, 2026. This marks a significant decline for the small-cap company, which operates within the miscellaneous industry. Over the past year, Genpact's performance has been relatively modest, with a return of 2.89%, significantly lagging behind the S&P 500's impressive 29.84% gain. Despite the recent price drop, Genpact maintains a market capitalization of USD 6,540 million and exhibits strong management efficiency, highlighted by a return on equity of 22.31%. The company also boasts a low debt-to-equity ratio of 0.15, indicating a conservative approach to leverage. Furthermore, Genpact has shown healthy long-term growth, with operating profit increasing at an annual rate of 10.73%. In terms of financial metrics, Genpact's price-to-earnings ratio stands at 12.00, while its dividend yield is notably high at 193.37%. The stock's 52-week high was recorded at USD 50.41, reflecting the volatility in its recent performance. Overall, Genpact's current position presents a complex picture of resilience amid market fluctuations.